Welcome!

News Feed Item

Serenus Biotherapeutics Strengthens Leadership With Appointments to Board and Management

Company Adds Team Members With Extensive Knowledge of Sub-Saharan African Markets and Global Biopharmaceutical Industry

SAN FRANCISCO, CA and JOHANNESBURG, SOUTH AFRICA -- (Marketwired) -- 07/24/14 -- Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world's leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Sub-Saharan Africa, today announced appointments to its board of directors and senior management team.

The company named to its board of directors Sbu Luthuli, former Chairman of Cipla Medpro; Dr. Nigel Fleming, founder and former Chairman of Athena Diagnostics; and Kazuhiro Umeda, former President of JAIC Singapore, Indonesia, and Thailand.

In addition, the company made appointments to its executive management team. It named Moosa Areff, who most recently served as CEO of Ranbaxy South Africa's Sonke Pharmaceuticals subsidiary, as its Chief Operating Officer. It also named Andrew de Pão, who served as Head of Marketing of the Prescription Division at Cipla South Africa, as its Chief Business Officer; and Nahum Johnson, former Business Unit Manager - State Institutional and Government at Cipla Medpro, as Director State and Institutional Business.

"We are pleased to have attracted a distinguished group of board members to guide us as we begin to implement our plans, enter into new partnerships, and grow our company," says Dr. Menghis Bairu, founder, Chairman, and CEO of Serenus Biotherapeutics. "The additions we have made to our executive team give us the people on the ground with intimate knowledge of the Sub-Saharan African landscape needed to execute on our strategy."

Mr. Luthuli noted that the appointments come as the Sub-Saharan African market is experiencing rapid economic development, the emergence of a burgeoning middle class, and a marked shift in disease profiles.

"The Sub-Saharan African pharmaceutical market is growing rapidly as lifestyle changes are driving a shift in disease burden from infectious to chronic diseases. Nevertheless, access to needed innovative therapeutics is still limited today," says Mr. Luthuli. "Serenus offers an African access platform that uniquely positions it to serve as a partner of choice for biopharmaceutical companies with innovative therapies in developed markets that appreciate the opportunities in the emerging markets of Sub-Saharan Africa, but may not have the expertise or networks needed to address the complexity of doing business in the region."

Below are bios of the Serenus Biotherapeutics appointees announced today.

Sbu Luthuli
Member of the Board of Directors
Mr. Luthuli is the CEO and Principal Officer of the Eskom Pension and Provident Fund, one of the largest self-administered pension funds in South Africa with assets under management in excess of $10.4 billion (R110 billion). Prior to this, he served as CEO of Ithala Bank Limited, where he transformed and grew the bank through the launch of new products and the introduction of electronic banking. He is a director at Telkom SA Limited and also serves as the Vice Chairman of Batseta, an industry organization representing pension fund trustees and principal officers. He was involved with Cipla Medpro (formerly Enaleni Pharmaceuticals Limited) for ten years and served as Chairman of the Board of Directors until its sale to Cipla India in 2013.

Dr. Nigel Fleming
Member of the Board of Directors
Dr. Fleming is founder and Chairman of G2B Pharma Inc., which is reformulating off-patent drugs to significantly improve their safety or efficacy. He founded and served as Chairman of Athena Diagnostics, a leading provider of advanced neurodiagnostic tests, used for neuromuscular and metabolic diseases. Dr. Fleming has served on various boards, including Exemplar, Impax Labs, Genmedica Therapeutics, A-Cube, Minoryx Therapeutics (as Chairman), and the Institute for OneWorld Health. He has also served as a Lecturer at Harvard Medical School. He earned his Ph.D. in Clinical Biochemistry from Cambridge University, and completed a post-doctoral fellowship at Boston University Medical School.

Kazuhiro Umeda
Member of the Board of Directors
Mr. Kazuhiro in 2005 joined Japan Asia Investment Co. Ltd., one of Japan's largest Venture Capital Firms. He served as Head of the CEO's Office, as well as President, heading up the Japan Asia Investment Company's Singapore, Indonesia, and Thailand office. He also founded Apricot, a natural food and drink company as a vehicle for commonly used pharmaceuticals, a revolutionary approach for pharmaceutical dosing. His early career included sales promotion for Daiichi Pharmaceuticals Group of Japan. He earned a master's and bachelor's degree in life sciences from the Tokyo University of Pharmacy and Life Sciences.

Moosa Areff
Chief Operating Officer
Mr. Areff comes to Serenus with 18 years of experience in the biopharmaceutical industry, starting as a sales representative and ultimately rising to become CEO at Ranbaxy South Africa's Sonke Pharmaceuticals. During his career he led the team that marketed and sold the first South African over-the-counter product in the Middle East and Africa and also negotiated and sold the first voluntarily licensed antiretroviral products into Sub-Saharan Africa. Mr. Areff served as Aspen Pharmacare's sales and marketing country manager for Nigeria, Uganda, and Libya for the launch of Gilead Sciences' Viread and Truvada. He also served as senior executive of new business development for Cipla Medpro and led commercial due diligence of the sale of Cipla Medpro to Enaleni Pharma. He has a diploma in journalism from Damelin College.

Andrew de Pão
Chief Business Officer
Mr. de Pão served as Head of Marketing for the Prescription Division at Cipla South Africa, as well as the commercial lead for Cipla South Africa Biosimilars Task Team. While there, he spearheaded the development and implementation of peri-, pre-, and post-launch clinical, marketing and communication campaigns across all prescription and OTX disease categories. Prior to joining Cipla South Africa, Mr. de Pão held a Healthcare Communications Consultant and Directors position at Publicis Global Healthcare Communications Group in the United Kingdom, where his team was involved in development of Global Brand Communication Strategies for various multinational pharmaceutical companies and provided corporate brand positioning and development and execution of digital and social media programs. He holds a Bachelor's in Physiology and Biochemistry and a Master's in Physiology from the University of Stellenbosch, South Africa.

Nahum Johnson
Director State and Institutional Business
Mr. Johnson has 20 years of experience in the biopharmaceutical industry. He most recently served as Pharma Unit Manager-State Institutional and Government at Cipla Medpro. Prior to that, he served as Key Account Manager-Public Sector for Adcock Ingram. He has a Bachelor's in Biochemistry from the University of the Western Cape, a postgraduate degree in Management Development Practice from the Department of Management Sciences, Business Graduate School UNISA; and is currently completing a Master's in Information Systems Knowledge Management.

About Serenus Biotherapeutics
Serenus Biotherapeutics is a privately held specialty biopharmaceutical company that specializes in late-stage drug development, in-licensing, registering, and commercializing therapies approved in the United States, Europe, and Japan to address unmet medical needs with high regional prevalence in the Sub-Saharan African market. For more information, please visit www.serenusbio.com

Contact:
Daniel Levine
Levine Media Group
(510) 280-5405
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that Pulzze Systems will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Pulzze Systems, Inc. provides infrastructure products for the Internet of Things to enable any connected device and system to carry out matched operations without programming. For more information, visit http://www.pulzzesystems.com.
SYS-CON Events announced today that Numerex Corp, a leading provider of managed enterprise solutions enabling the Internet of Things (IoT), will exhibit at the 19th International Cloud Expo | @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Numerex Corp. (NASDAQ:NMRX) is a leading provider of managed enterprise solutions enabling the Internet of Things (IoT). The Company's solutions produce new revenue streams or create operating...
If you’re responsible for an application that depends on the data or functionality of various IoT endpoints – either sensors or devices – your brand reputation depends on the security, reliability, and compliance of its many integrated parts. If your application fails to deliver the expected business results, your customers and partners won't care if that failure stems from the code you developed or from a component that you integrated. What can you do to ensure that the endpoints work as expect...
The Transparent Cloud-computing Consortium (abbreviation: T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data processing High speed and high quality networks, and dramatic improvements in computer processing capabilities, have greatly changed the nature of applications and made the storing and processing of data on the network commonplace.
WebRTC adoption has generated a wave of creative uses of communications and collaboration through websites, sales apps, customer care and business applications. As WebRTC has become more mainstream it has evolved to use cases beyond the original peer-to-peer case, which has led to a repeating requirement for interoperability with existing infrastructures. In his session at @ThingsExpo, Graham Holt, Executive Vice President of Daitan Group, will cover implementation examples that have enabled ea...
SYS-CON Events announced today that Tintri Inc., a leading producer of VM-aware storage (VAS) for virtualization and cloud environments, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Tintri VM-aware storage is the simplest for virtualized applications and cloud. Organizations including GE, Toyota, United Healthcare, NASA and 6 of the Fortune 15 have said “No to LUNs.” With Tintri they mana...
Major trends and emerging technologies – from virtual reality and IoT, to Big Data and algorithms – are helping organizations innovate in the digital era. However, to create real business value, IT must think beyond the ‘what’ of digital transformation to the ‘how’ to harness emerging trends, innovation and disruption. Architecture is the key that underpins and ties all these efforts together. In the digital age, it’s important to invest in architecture, extend the enterprise footprint to the cl...
SYS-CON Events announced today the Kubernetes and Google Container Engine Workshop, being held November 3, 2016, in conjunction with @DevOpsSummit at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA. This workshop led by Sebastian Scheele introduces participants to Kubernetes and Google Container Engine (GKE). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, students learn the key concepts and practices for deploying and maintainin...
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
Fifty billion connected devices and still no winning protocols standards. HTTP, WebSockets, MQTT, and CoAP seem to be leading in the IoT protocol race at the moment but many more protocols are getting introduced on a regular basis. Each protocol has its pros and cons depending on the nature of the communications. Does there really need to be only one protocol to rule them all? Of course not. In his session at @ThingsExpo, Chris Matthieu, co-founder and CTO of Octoblu, walk you through how Oct...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life sett...
Fact is, enterprises have significant legacy voice infrastructure that’s costly to replace with pure IP solutions. How can we bring this analog infrastructure into our shiny new cloud applications? There are proven methods to bind both legacy voice applications and traditional PSTN audio into cloud-based applications and services at a carrier scale. Some of the most successful implementations leverage WebRTC, WebSockets, SIP and other open source technologies. In his session at @ThingsExpo, Da...
SYS-CON Events announced today that ReadyTalk, a leading provider of online conferencing and webinar services, has been named Vendor Presentation Sponsor at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. ReadyTalk delivers audio and web conferencing services that inspire collaboration and enable the Future of Work for today’s increasingly digital and mobile workforce. By combining intuitive, innovative tec...
SYS-CON Events announced today that Secure Channels will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. The bedrock of Secure Channels Technology is a uniquely modified and enhanced process based on superencipherment. Superencipherment is the process of encrypting an already encrypted message one or more times, either using the same or a different algorithm.
Vidyo, Inc., has joined the Alliance for Open Media. The Alliance for Open Media is a non-profit organization working to define and develop media technologies that address the need for an open standard for video compression and delivery over the web. As a member of the Alliance, Vidyo will collaborate with industry leaders in pursuit of an open and royalty-free AOMedia Video codec, AV1. Vidyo’s contributions to the organization will bring to bear its long history of expertise in codec technolo...